moxifloxacin has been researched along with 2,2'-dipyridyl in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (2,2'-dipyridyl) | Trials (2,2'-dipyridyl) | Recent Studies (post-2010) (2,2'-dipyridyl) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 2,251 | 0 | 894 |
| Protein | Taxonomy | moxifloxacin (IC50) | 2,2'-dipyridyl (IC50) |
|---|---|---|---|
| Deoxyhypusine hydroxylase | Homo sapiens (human) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drlica, K; Malik, M; Wang, X; Zhao, X | 1 |
| Li, L; Liu, X; Liu, Y; Qu, Y; Wang, X; Zhao, X | 1 |
2 other study(ies) available for moxifloxacin and 2,2'-dipyridyl
| Article | Year |
|---|---|
Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death.
Topics: 2,2'-Dipyridyl; Anti-Bacterial Agents; Aza Compounds; Chloramphenicol; Escherichia coli; Fluoroquinolones; Microbial Viability; Moxifloxacin; Oxolinic Acid; Quinolines; Quinolones; Reactive Oxygen Species | 2010 |
Inhibitors of reactive oxygen species accumulation delay and/or reduce the lethality of several antistaphylococcal agents.
Topics: 2,2'-Dipyridyl; Anti-Bacterial Agents; Aza Compounds; Daptomycin; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Oxacillin; Quinolines; Reactive Oxygen Species; Staphylococcus aureus; Thiourea; Time Factors | 2012 |